arrow
Back
K

Kirstine Brown‐Frandsen

Dalhousie University

7H-index
8Paper Count
9.3KCitation Count
Published Papers 5
Publication Date
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial
err2023-04-11
err65
errOAAI
errMcGuire, Darren K.; Busui, Rodica P.; Deanfield, John; Inzucchi, Silvio E.; Mann, Johannes F. E.; Marx, Nikolaus; Mulvagh, Sharon L.; Poulter, Neil; Engelmann, Mads D. M.; Hovingh, G. Kees; Ripa, Maria Sejersten; Gislum, Mette; Brown-Frandsen, Kirstine; Buse, John B.
errShare
errSave
What is innovation in the area of medicines? The example of insulin and diabetes
err2019-08-06
err2
PREAI
errBaeres, F. M. M.; Gundgaard, J.; Brown-Frandsen, K.
errShare
errSave
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
err2019-04-01
err8
errOAAI
errBrown-Frandsen, Kirstine; Emerson, Scott S.; McGuire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Pratley, Richard E.; Zinman, Bernard; Ranthe, Mattis F.; Gron, Randi; Lange, Martin; Moses, Alan C.; Orsy, Petra; Buse, John B.
errShare
errSave
Liraglutide and Renal Outcomes in Type 2 Diabetes
err2017-08-31
err877
errOAAI
errMann, Johannes F. E.; Orsted, David D.; Brown-Frandsen, Kirstine; Marso, Steven P.; Poulter, Neil R.; Rasmussen, Soren; Tornoe, Karen; Zinman, Bernard; Buse, John B.
errShare
errSave
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
err2016-07-28
err5.7K
errOAAI
errMarso, Steven P.; Daniels, Gilbert H.; Brown-Frandsen, Kirstine; Kristensen, Peter; Mann, Johannes F. E.; Nauck, Michael A.; Nissen, Steven E.; Pocock, Stuart; Poulter, Neil R.; Ravn, Lasse S.; Steinberg, William M.; Stockner, Mette; Zinman, Bernard; Bergenstal, Richard M.; Buse, John B.
errShare
errSave